|
|
Relationships between serum miR-155, HP and MPO levels and lung function in patients with bronchial asthma |
YANG Xiaona1, ZHANG Ying1, HAN Xiao2 |
1. Department of Respiratory Disease; 2. Department of Clinical Laboratory, General Hospital of the Northern Theater Command of PLA, Shenyang 110016, China |
|
|
Abstract Objective To investigate the correlations between serum miR-155, HP and MPO levels and lung function in patients with bronchial asthma. Methods Sixty-two cases of bronchial asthma treated between November 2017 and September 2019 in our department were selected, 39 of whom were in the onset stage (the onset group), 23 were in the remission stage (the remission group), and another 12 health examinees were enrolled as the healthy group. The levels of serum miR-155(microRNA-155), HP (hydroxyproline) and MPO (myeloperoxidase) were measured and compared between the participants. Results The expressions of HP, MPO and miR-155 in the onset group were significantly higher than those in the healthy group (P<0.01) , and those of the remission group were significantly higher than in the healthy group (P< 0.01) The expressions of HP(mg/L), MPO(U/L)and miR-155 in the onset group were significantly higher than those of the remission group (1.97±0.98 vs 1.49±0.73, 757.28±111.63 vs 579.06±101.74, 2.89±0.93 vs 2.02±0.83,P<0.01). FVC, FEV1, FEV1/FVC, MMEF75/25, PEF in the onset group and remission group were significantly lower than those in the healthy group (P< 0.01), and those in the remission group were significantly lower than in the healthy group (P< 0.01). FVC(L), FEV1(L), FEV1/FVC(%), MMEF75/25(L/s), PEF(L/min) were significantly lower in the onset group than in the remission group (2.63±0.92 vs 3.12±0.76, 1.45±0.31 vs 1.87±0.30, 59.26±14.25 vs 73.73±10.04,0.41±0.09 vs 0.73±0.08, 138.95±15.06 vs 402.69±10.85,P<0.01). FVC, FEV1, FEV1/FVC, MMEF75/25, PEF were negatively correlated with HP, MPO and miR-155(P< 0.05). Conclusions The serum miR-155, HP and MPO levels of bronchial asthma are negatively correlated with lung function.
|
Received: 10 November 2019
|
|
|
|
|
[1] |
Robijn A L, Murphy V E, Gibson P G. Recent developments in asthma in pregnancy [J].Curr Opin Pulm Med, 2019, 25(1):11-17.
|
[2] |
Jonckheere A C, Bullens D M A, Seys S F. Innate lymphoid cells in asthma: pathophysiological insights from murine models to human asthma phenotypes[J].Curr Opin Allergy Clin Immunol,2019, 19(1):53-60.
|
[3] |
Sheinerman K S, Tsivinsky V G, Umansky S R. Analysis of organ-enriched microRNAs in plasma as an approach to development of Universal Screening Test: feasibility study[J]. J Translat Med,2013, 11(1):304-304.
|
[4] |
Sato K, Jimi S, Kusubata M. Generation of bioactive prolyl-hydroxyproline (Pro-Hyp) by oral administration of collagen hydrolysate and degradation of endogenous collagen[J].Int J Food Sci Tech,2019, 54(6):1976-1980.
|
[5] |
Mascio P D, Martinez G R, Miyamoto S, et al. Singlet molecular oxygen reactions with nucleic acids, lipids, and proteins[J]. Chem Rev, 2019, 119(3):2043-2086.
|
[6] |
中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(2016年版)[J]. 中华结核和呼吸杂志, 2016, 39(9):1-24.
|
[7] |
Gaertner V D, Michel S, Curtin J A, et al. Nocturnal asthma is affected by genetic interactions between RORA and NPSR1[J].Pediatr Pulm,2019, 54(6):847-857.
|
[8] |
Chen G, Luo L, Zhang M M, et al. Association Study of Myosin Heavy Chain 15 Polymorphisms with Asthma Susceptibility in Chinese Han[J]. Biomed Res Int,2019, 2019(119):1-11.
|
[9] |
Wu G P, Yang G H, Zhang R X, et al. Altered microRNA expression profiles of extracellular vesicles in nasal mucus from patients with allergic rhinitis.[J].Allergy Asthma Immun,2015, 7(5):449-457.
|
[10] |
Liu X L, Wang R F, Xiu-Hua H U, et al. Advanced study on microRNAs involved in prevention and treatment of respiratory system diseases[J].Chinese Pha Bul, 2015, 31(7):895-899.
|
[11] |
Trinh H K T, Pham D L, Kim S C, et al. Association of the miR-196a2, miR-146a, and miR-499 Polymorphisms with Asthma Phenotypes in a Korean Population[J].Mol Diagn Ther, 2017, 21(5):547-554.
|
[12] |
Bernard H, Guillon B, Drumare M F, et al. Allergenicity of peanut component Ara h 2: Contribution of conformational versus linear hydroxyproline-containing epitopes[J].J Allergy Clin Immunol, 2015, 135(5):1267-1274.
|
[13] |
Royce S G, Patel K P, Samuel C S. Characterization of a novel model incorporating airway epithelial damage and related fibrosis to the pathogenesis of asthma[J]. Lab Invest, 2014, 94(12):1326-1339.
|
[14] |
Tang X N, Zhang H J, Song G M, et al. Development of an XBP1 agonist, HLJ2, as a potential therapeutic agent for ulcerative colitis[J].CJPT, 2017, 109(10):970-971.
|
[15] |
Ge L, Ling C, Mo Q, et al. Total phenylethanoid glycosides and magnoloside Ia from Magnolia officinalis var. biloba fruits inhibit ultraviolet B-induced phototoxicity and inflammation through MAPK/NF-κB signaling pathways [J]. Rsc Advances, 2018, 8(8):4362-4371.
|
[16] |
梁 瑞,惠增骞,王家林,等.FEV1/FVC对局限期小细胞肺癌预后的影响[J]. 武警医学, 2019, 30(7): 607-610.
|
[17] |
Harati B, Shahtaheri S J, Karimi A, et al. Evaluation of Respiratory Symptoms among Workers in an Automobile Manufacturing Factory, Iran[J]. Iran J Public Health,2018, 47(2):237-245.
|
[18] |
杨 娟, 刘恩梅, 刘翠青,等. 肺炎支原体抗体阳性对咳嗽变异性哮喘患儿肺功能的影响[J]. 中国微生态学杂志, 2014, 26(7):805-808.
|
[19] |
Tian X Y, Liu C H, Wang D X, et al. Spirometric reference equations for elderly Chinese in Jinan aged 60-84 years[J].Chin Med J,2018, 131(9):1016-1022.
|
[20] |
Gao Y, Fei Q, Qi R, et al. Shuang-Huang-Lian Attenuates airway hyperresponsiveness and inflammation in a shrimp protein-induced murine asthma model[J].Evid-Based Compl Alt, 2019, 2019(12):1-9.
|
[1] |
. [J]. Med. J. Chin. Peop. Armed Poli. Forc., 2018, 29(8): 815-818. |
|
|
|
|